Brain Tumor
Matrix metalloproteinases are tumor-specific markers in glioma patients
Published in Cancer Weekly, January 20th, 2004
"The members of the matrix metalloproteinase family (MMP) have the ability to degrade macromolecules of the extracellular matrix and are responsible for tumor invasion and infiltration, limiting the effectiveness of the neurosurgical resection of brain tumors. Among the glial brain tumors, astrocytomas and oligodendrogliomas are the most important tumor entities and require a different therapeutic approach," according to medical investigators in Germany.
"To determine the pattern of MMP expression in astrocytic and oligodendroglial tumors, sections of astrocytic and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-01-20)
More Articles from Cancer Weekly
- Antineoplastic Agents
A closed-system protective device reduces exposure to antineoplastic agents - Liver Cancer
A high percentage of liver cancers have elevated liver-intestine cadherin - Liver Transplantation
Imaging can detect complications of liver transplantation - Lung Cancer
Aspirin use does not reduce lung cancer risk in men - Lung Cancer
Certain GST genetic polymorphisms are related to increased lung adenocarcinoma - Lung Cancer
Clinical trial under way for patients with brain metastases - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
